hrp0098fc15.3 | Late Breaking | ESPE2024

Assessment of actionable secondary genetic findings in a large cohort of children with short stature

Carneiro Rezende Raissa , Liberatoscioli Menezes de Andrade Nathalia , de Polli Cellin Laurana , Maria Santillan Ana , da Cunha Scalco Renata , Augusto de Lima Jorge Alexander

Introduction: Genetic investigation in patients with short stature allows diagnostic definition and impacts therapeutic decisions, clinical follow-up, and genetic counseling. That said, next-generation sequencing has created a new clinical challenge by allowing the identification of findings unrelated to the complaint that prompted testing. The ACMG published a list of actionable incidental findings that includes genes whose variants should be reported to pati...

hrp0098p2-155 | GH and IGFs | ESPE2024

Short and long-term response to rhGH therapy in short children born at very low birth weight.

Christianne Malaquias Alexsandra , Kataoka Homma Thais , Castelo Branco Dantas Naiara , Lucheze Freire Bruna , Vasco de Albuquerque Albuquerque Edoarda , Jorge Prado Arnhold Ivo , Cunha Scalco Renata , Augusto de Lima Jorge Alexander

Introduction: Extrauterine growth retardation is a common characteristic among children born at very low birth weight (VLBW). Over time, recombinant human growth hormone (rhGH) has been used in this group based on indications for children born small for gestational age (SGA). However, this group represents an extreme phenotype to the majority of children born SGA, and data on the outcomes of this therapy in this group are limited.<strong...